News & Latest Announcements
The Future of Early-Phase Clinical Trials: AI, Biomarkers & Smarter Study Designs
A New Era in Early-Phase Trials Early-phase clinical trials—particularly First-in-Human (FIH) and Phase I studies—are the backbone of drug development, determining whether a new treatment is safe,…
Read article
The Festival of Biologics in San Diego – through our Accelsiors lens
This year, Accelsiors had the unique opportunity to participate in the Festival of Biologics USA, held at the San Diego Convention Center on April 23–24. With…
Read article
Biomarkers in Drug Development: Transforming Clinical Trials for Neurodegenerative Diseases
The Role of Biomarkers in Accelerating Drug Development Imagine developing a new drug for Alzheimer’s disease (AD)—only to discover halfway through clinical trials that many participants…
Read article
Biosimilars on the Brink of Transformation: What EMA’s 2025 Vision and FDA Insights Mean for You
Are you ready for the next big shift in biosimilar development? The biosimilar landscape is evolving at lightning speed, driven by groundbreaking regulatory updates from the…
Read article
How Biomarkers Are Revolutionizing Biosimilar Development: Trends, Challenges, and Opportunities
Introduction Biosimilars have been a transformative force in healthcare, providing more affordable versions of biologics to treat serious illnesses. However, their development remains a costly and…
Read article
A recap of KgPSA’s 3rd Mini-Congress
On October 5-6, 2024, Accelsiors had the honor of sponsoring the 3rd Mini-Congress of Kragujevac Pharmacy Student’s Association (KgPSA). This year’s topic, “Anxiety-an Obstacle to Success”,…
Read article
Accelsiors at ASCO 2024: A Gateway to Collaboration and Innovation in Oncology
The recent American Society of Clinical Oncology (ASCO) conference served as a platform for Accelsiors to showcase our expertise, forge valuable connections, and reinforce our commitment…
Read article
Significant milestone in the golexanolone Phase 2 study!
We are happy to announce that the first two patients have been successfully randomized in the Phase 2 portion of the clinical trial evaluating golexanolone for…
Read article
Accelsiors at Bio Korea 2024
We’re still under the impact of Bio Korea 2024. This prestigious event brought together leading minds and organizations in biotechnology from around the world to discuss…
Read article